Agilon Health (NYSE:AGL) Price Target Cut to $1.50 by Analysts at Barclays

Key Points

• Barclays has reduced its price target for Agilon Health from $3.00 to $1.50 while maintaining an "underweight" rating on the stock, suggesting a potential upside of 61.12% from the stock's previous close.
• Agilon Health reported a loss per share of ($0.25) for the latest quarter, missing estimates and showing a decline in revenue compared to the prior year.
• As of now, Agilon Health has a consensus rating of "Hold" with a target price of $4.07 based on ratings from multiple analysts, indicating mixed sentiment towards the stock.

Agilon Health (NYSE:AGL - Get Free Report) had its price target lowered by Barclays from $3.00 to $1.50 in a report issued on Wednesday,Benzinga reports. The firm currently has an "underweight" rating on the stock. Barclays's target price would suggest a potential upside of 74.22% from the company's previous close.

A number of other equities analysts have also recently commented on AGL. Benchmark dropped their target price on Agilon Health from $4.00 to $1.50 and set a "buy" rating for the company in a report on Wednesday. Cowen reaffirmed a "hold" rating on shares of Agilon Health in a research note on Tuesday, April 15th. Robert W. Baird reduced their target price on shares of Agilon Health from $6.00 to $5.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 15th. TD Cowen raised their target price on shares of Agilon Health from $3.50 to $6.00 and gave the stock a "hold" rating in a report on Tuesday, April 15th. Finally, Wells Fargo & Company cut their price target on shares of Agilon Health from $6.00 to $5.00 and set an "overweight" rating on the stock in a report on Tuesday, May 13th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Agilon Health currently has an average rating of "Hold" and an average price target of $4.07.

Agilon Health Trading Down 1.6%

AGL traded down $0.01 during trading hours on Wednesday, hitting $0.86. The company's stock had a trading volume of 7,546,530 shares, compared to its average volume of 6,671,493. The business's 50-day moving average price is $2.10 and its 200-day moving average price is $3.17. Agilon Health has a 12 month low of $0.71 and a 12 month high of $6.08. The stock has a market cap of $356.82 million, a price-to-earnings ratio of -1.12 and a beta of 0.14.

Agilon Health (NYSE:AGL - Get Free Report) last announced its earnings results on Monday, August 4th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.14). Agilon Health had a negative net margin of 5.35% and a negative return on equity of 66.76%. The business had revenue of $1.39 billion for the quarter, compared to analysts' expectations of $1.47 billion. During the same quarter in the prior year, the company posted ($0.07) earnings per share. The firm's quarterly revenue was down 5.9% compared to the same quarter last year. On average, analysts forecast that Agilon Health will post -0.59 earnings per share for the current year.

Institutional Investors Weigh In On Agilon Health

A number of institutional investors and hedge funds have recently bought and sold shares of the company. SG Americas Securities LLC increased its stake in shares of Agilon Health by 1,271.3% during the first quarter. SG Americas Securities LLC now owns 144,189 shares of the company's stock valued at $624,000 after buying an additional 133,674 shares during the period. Wealth Enhancement Advisory Services LLC increased its position in Agilon Health by 21.8% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 99,697 shares of the company's stock valued at $432,000 after purchasing an additional 17,866 shares during the period. Nisa Investment Advisors LLC increased its position in Agilon Health by 244.9% during the 1st quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company's stock valued at $41,000 after purchasing an additional 6,783 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in shares of Agilon Health by 41.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 338,529 shares of the company's stock valued at $644,000 after purchasing an additional 98,377 shares in the last quarter. Finally, Cerity Partners LLC purchased a new stake in shares of Agilon Health in the 4th quarter worth approximately $34,000.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.